The effectiveness of treatments for Kashin–Beck disease: a systematic review and network meta-analysis

Zou, Kun; Hu, Jinliang; Zhou, Qiao; Su, Jiang; Dong, Birong; Zhang, Weiya

Abstract

Objectives: This study aims to evaluate the efficacy of treatments for Kashin–Beck disease (KBD). Method: We searched PubMed, Cochrane Central Register of Controlled Trials, Embase, Web of Science, SinoMed, Chinese National Knowledge Infrastructure, reference lists and published systematic reviews and registries of ongoing trials through May 2015 for randomised controlled trials (RCTs) of treatments for KBD. Outcomes of interest were pain, function, stiffness, overall clinical improvement, radiographic improvement (X-ray) and adverse events. Frequentist network meta-analyses were conducted using random-effects consistency model to assess the efficacy of treatments for KBD. Results: Forty-four RCTs with 9815 participants were included in the review. In children or adolescents, selenium (risk ratio 1.88, 95% confidence interval (CI) 1.51–2.33), vitamin C (2.03, 1.40–2.95) and aspirin (2.14, 1.12–4.08) were effective for radiographic structure improvement. In adults, chondroitin plus glucosamine was the best for pain (standardised mean difference 1.46, 95% CI 1.07–1.85), followed by intra-articular injection of hyaluronic acid (IAH) (1.09, 0.70–1.48), chondroitin (0.84, 0.47–1.21), diclofenac (0.63, 1.18–1.08), naproxen (0.55, 0.12–0.98), meloxicam (0.52, 0.03–1.01) and glucosamine (0.40, 0.13–0.67) compared to placebo, with similar results for other clinical outcomes in adults. However, the strength of most evidence was limited by the small number of trials with low to moderate quality. Conclusions: Selenium supplement has demonstrated some benefits for structural improvement of the disease in children. Chondroitin, glucosamine, IAH and nonsteroid anti-inflammatory drugs are effective for symptom improvements of KBD in adults. Evidence of surgical and complementary treatments for symptoms and aspirin and vitamin C for structure has yet to be established.Key Points• There were 23 nutraceuticals, pharmaceuticals and surgical and complementary treatments assessed for Kashin–Beck disease (KBD) in randomised trials.• Among the 23 treatments, chondroitin, glucosamine, IAH and non-steroid anti-inflammatory drugs are more effective than placebo to relieve symptoms for adults with KBD.• Selenium supplement is more effective than placebo for radiographic improvement in children or adolescents.• The efficacy of surgeries, aspirin, vitamin C and complementary treatments for KBD has not been established yet.

Citation

Zou, K., Hu, J., Zhou, Q., Su, J., Dong, B., & Zhang, W. (2019). The effectiveness of treatments for Kashin–Beck disease: a systematic review and network meta-analysis. Clinical Rheumatology, 38(12), 3595-3607. https://doi.org/10.1007/s10067-019-04704-0

• Journal Article Type: Article
• Acceptance Date: Jul 17, 2019
• Online Publication Date: Aug 2, 2019
• Publication Date: 2019-12
• Deposit Date: Dec 9, 2019
• Journal: Clinical Rheumatology
• Print ISSN: 0770-3198
• Electronic ISSN: 1434-9949
• Publisher: Springer Verlag
• Peer Reviewed: Peer Reviewed
• Volume: 38
• Issue: 12
• Pages: 3595-3607
• DOI: https://doi.org/10.1007/s10067-019-04704-0
• Public URL: https://nottingham-repository.worktribe.com/output/3448220
• Publisher URL: https://link.springer.com/article/10.1007%2Fs10067-019-04704-0